# The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure

> **NCT00769210** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 12 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00769210
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769210, "The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00769210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*